baber/WOPTO huggingface dataset:
Patent EP-0887804-A1 (EP)
Inventor: FERRANT RICHARD
IPC: G11C7/06
Filed: 1998-06-03
Abstract: The procedure involves using a pre-charge stage for a bit line (B1) and a reference line (B2) for carrying the potential (Vb1,Vb2) of the lines to a reference potential (Vref) level which is different from the initial potential memorised in the cell (C11). A selection stage is used for the memory cell for producing a modification of the potential (Vb1) of the bit line (B1), thus creating an initial difference between the potentials of the bit line and the reference line. It also has a discharge stage for the bit line and the reference line, which have discharge currents running through them, and an output signal (OUT1) production stage representing the values of the output currents.
Patent EP-0927869-A1 (EP)
Inventor: D ANNA RICCARDO
IPC: G01L5/10
Filed: 1998-12-30
Abstract: A device and a method are described for the
measurement of heavy strains of products subject to
thermal and/or mechanical stresses, characterised in that
it comprises a rope-shaped member of metallic material
and a measurement device of the resistance and/or the
voltage connected to the ends of said rope-shaped member,
the arrangement being such that said rope-shaped member
is apt to be arranged in an electrically insulated and
sliding manner onto the surface of the product subject to
strains to provide to the reading device an electric
signal corresponding to the strain of said product.
Patent EP-0966214-A1 (EP)
Inventor: JOHNSON SUSAN GWYNNETH
IPC: A43B1/14
Filed: 1998-02-06
Abstract: A lining material for footwear comprises up to 40 % by weight binder fibre e.g. polypropylene and the remainder substantially bulk fibre e.g. polyester. The binder fibre has a melting temperature up to 200 °C and at least 70 °C lower than the bulk fibre. The material is heat shrunk in its manufacture to consolidate the material by fusion incorporation of the binder fibre with bulk fibre, suitably by exposure to hot air.
Patent EP-0894277-A1 (EP)
Title: Fibres optiques traitees munies de revetements primaires pelables et procedes de fabrication et d'utilisation de ces dernieres
Inventor: SHUSTACK PAUL J
IPC: C03C25/10
Filed: 1998-01-23
Abstract: La présente invention concerne des fibres optiques traitées (10) munies de revêtements (14) primaires durcissables par rayonnement contenant des oligomères. En particulier, les revêtements primaires (14) peuvent comprendre un ou plusieurs oligomères uréthane à terminaison (méth)acrylate; des diluants monomères; un promoteur d'adhésion optique silane, un photoamorceur et des stabilisateurs. Les revêtements primaires (14) sont composés d'un matériau qui, lorsqu'il est durci, présente une faible adhérence au verre, une résistance à la traction élevée et un allongement de rupture d'au moins 75 %. L'invention se rapporte également au procédé de préparation de ces fibres optiques (10) et aux revêtements (14) en soi.
Patent EP-1051855-A1 (EP)
Inventor: HALL ESTILL THONE JR
IPC: G03B21/62
Filed: 1998-01-29
Abstract: A projection television (10) has image projectors (14, 16, 18) and optics for projecting images of different colors, producing a quantity of scattered light that is incident upon at least a portion of a projection screen (22). The projection screen (22) includes a three-dimensional hologram (26) disposed on a substrate (24) and representing a three-dimensional interference array that receives images from the projectors (14, 16, 18) on a first side and displays the images on a second side with controlled light dispersion of all the displayed images. The screen (22) is specifically configured to exclude a high proportion of light that is incident from angles other than normal to the screen (22), substantially eliminating the effects of the scattered light and improving image contrast.
Patent EP-0960106-A1 (EP)
Inventor: THURKAUF ANDREW
IPC: C07D295/096
Filed: 1998-01-29
Abstract: Disclosed are compounds of the formula: or the pharmaceutically acceptable addition salts thereof wherein: R<SUB>1 </SUB>is halogen or C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; and R<SUB>2 </SUB>and R<SUB>3 </SUB>are the same or different and represent hydrogen, halogen, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy, alkylthio, hydroxy, amino, mono(C<SUB>1</SUB>-C<SUB>4</SUB>)alkylamino, di(C<SUB>1</SUB>-C<SUB>4</SUB>)alkylamino, or R<SUB>2 </SUB>and R<SUB>3 </SUB>together represent a 4 carbon alkenylene moiety that together with the phenyl ring to which they are attached form a naphthyl moiety, which compounds are useful in the treatment of neuropsycological diseases such as schizophrenia, psychotic depression and mania.
Patent EP-0958562-A1 (EP)
Inventor: MYRON DOUGLAS D
IPC: H05B37/02
Filed: 1998-02-04
Abstract: A multiple sensing technology-based occupancy sensor. Ultrasonic and infrared sensors are used to produce first and second occupancy estimator signals that are combined using a fusion based detection algorithm to produce a combined estimator signal. The combined estimator is then used to switch electrical loads when the combined estimator signal is above a predetermined threshold. The result is an occupancy sensor that has a very high probability of occupancy detection and a low probability of false tripping. In addition, infrared sensitivity is adjusted based upon an estimation of the background noise in order to minimize the occurrence of false tripping.
Patent EP-1007635-A1 (EP)
Inventor: REDBRAKE-ADAMS CLAUDIA
IPC: C12N5/071
Filed: 1998-01-22
Abstract: An agent for dehydrating corneas, in particular eye corneas for organ culture, contains the culture medium and as dehydrating substance hydroxyethylstarch with a mean molecular weight MW from 70,000 to 200,000, an MS substitution degree from 0.15 to 0.5, a DS substitution degree from 0.15 to 0.5 and a C2-C6 substitution ratio at the anhydroglucose units ≥ 8. The dehydrating substance is preferably hydroxyethylstarch with a mean molecular weight MW 130,000 ± 20,000, an MS substitution degree from 0.38 to 0.45, a DS substitution degree from 0.32 to 0.40 and a C2-C6 substitution ratio at the anhydroglucose units from 8 to 20. The hydroxyethylstarch is used in a concentration from 1 to 20 (weight/vol.) %, preferably from 2 to 15 (weight/vol.) %, and in particular of 7.5 % (weight/vol.). Also disclosed is the use of this hydroxyethylstarch as a dehydrating substance for the organ culture of corneas, in particular eye corneas, and the use of this hydroxyethylstarch for preparing a dehydrating agent for corneas, in particular eye corneas for organ culture.
Patent EP-0918169-A1 (EP)
Inventor: TAKEUCHI HISAO
IPC: F16C33/04
Filed: 1998-02-23
Abstract: A dynamic pressure pneumatic bearing
structure by which a whirl can be avoided not
only at the time of the high speed rotation but
also at the time of the low speed rotation, the
frequency of the increase of a floating
revolution at the time of the start or stop of the
rotation is reduced and, further, the floating
revolution can he shifted to a low revolution
side. This structure has a shaft (1) and a
bearing (2). Trenches (11) are formed in the
outer circumferential surface of the shaft (1).
Each trench (11) is composed of two or more
recesses which are formed continuously in a
circumferential direction and have practically
different depths. The cross section of the trench
(11) which is perpendicular to an axial line is
asymmetrical with respect to the
circumferential direction. The circumferential distance (a) between the cross point (15) of a line (C) connecting the deepest point (14) of the
trench (11) to the center (0) of the shaft (1) and the one side edge (16) of a trench (11) on the envelope line (Q) of the shaft (1) which is
provided on the downstream side of an air flow (P) produced at the time of rotation with respect to the cross point (15) is larger than the
circumferential distance (b) between the cross point (15) and the other side edge (17) of a trench (11) which is provided on the upstream side
of the air flow (P) with respect to the cross point (15). The ratio (d 2 /d 1 ) of the average depth (d 2 ) of the relatively shallow parts of the
trenches (11) to the average depth (d 1 ) of the relatively deep parts of the trenches (11) is smaller than 0.3. The dynamic pressure pneumatic
bearing structure can be applied to the rotation driving unit of a magnetic recorder, a laser beam printer, etc.
Patent EP-0958243-A1 (EP)
Inventor: GARD DAVID RICHARD
IPC: C01F11/02
Filed: 1998-01-30
Abstract: Procédé pour préparer un hydroxyde de métal alcalino-terreux, consistant à faire réagir un oxyde de métal alcalino-terreux particulaire dont les particules ont une grosseur comprise dans une fourchette d'environ 100 νm à environ 10 000 νm, avec une quantité d'eau, pendant une durée et à une température suffisantes pour entraîner une réaction efficace, ce qui permet de préparer un hydroxyde de métal alcalino-terreux.
Patent EP-0963239-A1 (EP)
Inventor: BAURMEISTER ULRICH
IPC: B01D61/38
Filed: 1998-01-31
Abstract: The present invention relates to a membrane-fitted module and its process of manufacture, said module containing at least two groups of hollow fibers (8, 9), arranged in layers and loaded separately. The membrane-fitted module presents a housing shell comprising a groove-like central part (1) open on the upper side of the module as well as adjacent terminating elements (2, 3), which are also open on their upper side, each having as many arms (4, 5, 6, 7) as there are groups. In the housing shell are inserted groups of hollow fibres (8, 9) in stacked layers, arranged in the longitudinal direction of the central part (I). The ends of the membrane comprised of different groups of hollow fibers are placed in different arms (4, 5, 6, 7) of said terminating elements and embedded in a sealing material (10, 11) so as to leave open at least one end of the hollow-fibre membrane. Both the central part (1) of the housing shell and the terminating elements (2, 3) are tightly closed using a covering device (27, 36) which features around the hollow-fibre membranes an outer cavity (17) also filled with a fluid.
Patent EP-0910191-A1 (EP)
Inventor: KITADE TAKASHI
IPC: H04L5/16
Filed: 1998-04-02
Abstract: Radio communication equipment which performs radio
communication by the TDD system, wherein a starting timing signal
indicating the leading sign of a random transmission-reception slot
pattern is transmitted to a random transmission-reception generating
device from a starting timing recognizing device and the generating
device randomly selects transmission or reception to transfer the
selected transmission or reception mode to a slot controller. The slot
controller randomizes the frequency in synchronism with the turning
on/off period of transmission by controlling a framing device and a
transmission/reception change-over switch in accordance with a
randomly selected transmission or reception slot.
Patent EP-0966518-A1 (EP)
Inventor: BLASEY GERHARD
IPC: C11D17/00
Filed: 1998-03-04
Abstract: A process for making a detergent tablet by forming a disintegrating agent by compacting cellulose or a cellulose derivative, forming disintegrating agent particles comprising the disintegrating agent, dry mixing a washing- or cleaning-active substance and an amount of the disintegrating agent particles effective to rapidly dissolve or disperse the composition in water, and shaping the resulting mixture into a tablet. The disintegrating agent particles have a particle size distribution of less than 10% by weight smaller than about 0.2 mm particle size and no more than 1% by weight of dust-fine particles.
Patent EP-1074545-A1 (EP)
Inventor: HIDAKA HIROYOSHI
IPC: A61P31/18
Filed: 1998-04-23
Abstract: This invention relates to isoquinolinesulfonamide
derivatives represented by the following formula (1):
 
wherein A represents a linear or branched alkylene
group, R 1  represents a hydrogen atom, an hydroxyl,
alkoxy or alkyl group or the like, R 2  represents a
hydrogen atom, an alkyl group or the like, R 3 
represents a hydrogen atom, an alkyl group or the like,
and R 4  and R 5  may be the same or different and
individually represent hydrogen atoms or lower alkyl
groups; N-oxides and salts thereof; and solvates
thereof. This invention is also concerned with
pharmaceutical compositions, which contain the
derivatives, N-oxides, salts, or solvates. These
derivatives, N-oxides, salts, and solvates have viral
proliferation inhibiting activities and are useful as
AIDS therapeutics.
Patent EP-0973964-A1 (EP)
Title: Silicium a auto-interstices predominants, presentant un taux de defauts faible
Inventor: FALSTER ROBERT
IPC: C30B15/00
Filed: 1998-04-09
Abstract: L'invention concerne un silicium monocristallin en lingot ou en plaquette, qui contient une région symétrique axialement, exempte de défauts ponctuels intrinsèques agglomérés, ainsi que son procédé de préparation. Le procédé de tirage du lingot de silicium monocristallin consiste à moduler (i) la vitesse de croissance, v, (ii) le gradient de température axial instantané, G0, pendant la croissance d'une partie à diamètre constant du cristal dans une plage de températures allant de la température de solidification jusqu'à une température d'au moins 1 325 °C, et (iii) la vitesse de refroidissement du cristal d'une température de solidification jusqu'à environ 1 050 °C, de sorte qu'un segment axialement symétrique sensiblement exempt de défauts ponctuels intrinsèques agglomérés soit produit. Cette région symétrique axialement s'étend vers l'intérieur, depuis le bord circonférentiel du lingot, présente une largeur mesurée depuis le bord circonférentiel en direction de l'axe central du lingot représentant au moins environ trois dixièmes de la longueur du rayon de ce dernier, et présente une longueur mesurée le long de l'axe central d'au moins environ deux dixièmes de la longueur de la partie à diamètre constant du lingot.
Patent EP-0969911-A1 (EP)
Title: Filtre a air
Inventor: CARLE THOMAS
IPC: B01D46/24
Filed: 1998-03-12
Abstract: L'invention concerne un filtre à air, s'utilisant notamment pour épurer l'air de combustion de moteurs à combustion interne. Ce filtre comprend un élément filtrant (21) exempt de métal constitué d'un support filtrant (33) plié en accordéon. Ledit support filtrant forme un cylindre creux et sur ses faces d'about, il est prévu des plaques terminales (34 36) en élastomère thermoplastique ou en polyuréthane thermoplastique.
Patent EP-0977750-A1 (EP)
Inventor: ANGIBAUD PATRICK RENE
IPC: C07D401/14
Filed: 1998-04-17
Abstract: This invention concerns compounds of formulathe pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein the dotted line represents an optional bond; X is oxygen or sulfur; R1 and R2 each independently are hydrogen, hydroxy, halo, cyano, C1-6alkyl, trihalomethyl, trihalomethoxy, C2-6alkenyl, C1-6alkyloxy, hydroxyC1-6alkyloxy, C1-6alkyloxyC1-6alkyloxy, C1-6alkyloxycarbonyl, aminoC1-6alkyloxy, mono- or di(C1-6alkyl)aminoC1-6alkyloxy, Ar1, Ar1C1-6alkyl, Ar1oxy, Ar1C1-6alkyloxy; or when on adjacent positions R1 and R2 taken together may form a bivalent radical; R3 and R4 each independently are hydrogen, halo, cyano, C1-6alkyl, C1-6alkyloxy, Ar1oxy, C1-6alkylthio, di(C1-6alkyl)amino, trihalomethyl, trihalomethoxy; R5 is hydrogen, halo, cyano, optionally substituted C1-6alkyl, C1-6alkyloxycarbonyl or Ar1; or a radical of formula -OR10, -SR10, -NR11R12; R6 is an optionally substituted imidazolyl moiety; R7 is hydrogen or C1-6alkyl provided that the dotted line does not represent a bond; R8 is hydrogen, C1-6alkyl or Ar2CH2 or Het1CH2; R9 is hydrogen, C1-6alkyl, C1-6alkyloxy or halo, or R8 and R9 taken together may form a bivalent radical; Ar1 and Ar2 are optionally substituted phenyl and Het1 is optionally substituted pyridinyl; having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Patent EP-1005515-A1 (EP)
Inventor: BRENNEK A
IPC: C07C4/06
Filed: 1998-06-08
Abstract: L'invention concerne un procédé améliorant la conversion d'une charge d'hydrocarbures en oléfines légères, qui consiste à mélanger ladite charge avec une dioléfine pour constituer un mélange, puis à mettre ce mélange en contact avec un catalyseur de craquage zéolitique. De préférence, le catalyseur est mis en contact à une température de réaction comprise entre 500° C environ et 750° C environ, et la charge s'écoule à une vitesse spatiale horaire en poids compris entre 0,1 Hr-1 environ et 100 Hr-1 environ. La dioléfine peut être un hydrocarbure à chaîne droite, ramifiée ou cyclique ayant au moins deux liaisons Π. De préférence, la dioléfine est un hydrocarbure ayant de 4 à 20 atomes de carbone.
Patent EP-0989875-A1 (EP)
Title: Appareil destine a la fourniture de gaz respirable
Inventor: KENYON BARTON JOHN
IPC: A61M16/16
Filed: 1998-06-18
Abstract: La présente invention concerne un appareil (10) destiné à la fourniture de gaz respirable. Cet appareil (10) comporte un générateur de courant de gaz (12), une évacuation de gaz (14), un organe de raccordement (21) monté entre le générateur de courant de gaz (12) et une sonde manométrique (20). En l'occurrence, l'organe de raccordement comporte un orifice d'admission (22) de raccordement et un orifice d'évacuation (24) de raccordement, une sonde manométrique (20) étant montée entre l'orifice d'admission (22) de raccordement et l'évacuation de gaz (14). L'organe de raccordement (21) est conçu pour un raccordement sélectif sur un conduit (30) constituant un trajet d'écoulement direct de l'orifice d'admission (22) de raccordement vers l'orifice d'évacuation (24) de raccordement ou vers un humidificateur (26) monté entre l'orifice d'admission (22) de raccordement et l'orifice d'évacuation (24) de raccordement.
Patent EP-1001805-A1 (EP)
Inventor: ZABRISKIE JOHN B
IPC: C07K9/00
Filed: 1998-06-17
Abstract: Cette invention concerne l'utilisation d'anticorps dirigés contre le mucopeptide du groupe A pour le traitement du choc septique et de la polyarthrite rhumatoïde, ainsi que l'identification de peptides spécifiques pouvant être utilisés dans ces traitements. Cette invention porte sur des procédés d'utilisation des anticorps dirigés contre le mucopeptide du groupe A; dans lesquels on utilise comme moyen d'identification des peptides spécifiques, sur les peptides spécifiques eux-mêmes et sur des procédés d'utilisation desdits peptides. Dans certaines formes de réalisation, les peptides spécifiques servent de mimétiques pour ces anticorps. Ces peptides peuvent être administrés à un sujet animal pour le blocage de l'action microbienne qui amorce la polyarthrite rhumatoïde par l'intermédiaire du facteur de nécrotumorale. On peut également utiliser les peptides spécifiques de cette invention pour immuniser des individus sujets à la polyarthrite rhumatoïde pour empêcher la progression des maladies. Dans d'autres formes de réalisation, les peptides servent de partenaires de liaisons pour ces anticoprs.
Patent EP-1010071-A1 (EP)
Inventor: COHEN ALAIN
IPC: G06F19/00
Filed: 1998-07-01
Abstract: La présente invention concerne un procédé, un appareil et un support apte à être lu par ordinateur permettant d'exécuter une simulation à événements discrets au moyen d'une liste d'événements comprenant des événements. Dans la liste d'événements, un événement est indiqué comme événement de tête, et chaque événement est indiqué comme événement non calculé, pré-calculé ou en cours de calcul. Un événement non calculé est sélectionné et transféré vers un processus de pré-calcul d'événement appartenant à un groupe d'au moins un processus de pré-calcul d'événement, lequel effectue un calcul de l'événement non calculé sélectionné. Un événement de tête non calculé est exécuté, et un événement de tête pré-calculé est vérifié.
Patent EP-1031570-A1 (EP)
Inventor: GOLOSCHAPOV NIKOLAI MIKHAILOVI
IPC: A61K31/455
Filed: 1998-08-11
Abstract: The present invention pertains to the field of medicine and more precisely relates to a
novel immuno-modulator of the following formula
 
which exhibits anti-microbial and anti-mycobacterial activities. This modulator is
produced by reacting equimolecular amount of 6-methyluracyl-5-sulphochloride and
isoniazide in acetonitrile at a high temperature. The preparation is practically not toxic
(LD 50  in severe conditions exceeding 7000 mg/kg) and can be used according to a given
clinical tests for expressing the immuno-modulating and anti-mycobacterial activity. This
preparation can be used for correcting various immuno-deficiecies including in HIV-infected
patients as well as for treating mycobacterioses such as leprosy, tuberculosis, etc.
This preparation can be administrated internally or parenterally. The compound described
in the present invention represents the active substance of this pharmaceutical preparation,
wherein said preparation can be used against secondary various immuno-deficiecies or
mycobacterioses.
Patent EP-1001988-A1 (EP)
Inventor: FLESCH INGO
IPC: C07K14/49
Filed: 1998-07-20
Abstract: Verfahren und Vorrichtung zur Herstellung autologer, thrombozytärer Wachstumsfaktoren (Growth Factors) sowie System als Bestandteil der Vorrichtung zur Herstellung autologer Growth Factors. Bei dem erfindungsgemässen Verfahren zur Herstellung autologer Growth Factors wird aus Blut ein Thrombozytenkonzentrat gewonnen, in das Thrombozytenkonzentrat wird sodann eine definierte Menge von Thrombin und Calcium eingebracht, darauffolgend wird entstehendes Thrombozytenagglomerat von einer die die Wachstumsfaktoren enthaltenen Lösung getrennt. Die hierbei gewonnene Lösung wird portioniert und gefroren.
Patent EP-1109681-A1 (EP)
Inventor: RATLIFF BILLY JOE JR
IPC: B60C13/02
Filed: 1998-09-02
Abstract: Cette invention concerne un flanc(12) de pneu (10) qui possède une surface (13) comprenant des motifs de conceptions différentes. Le motif A comprend une marque formée par plusieurs arêtes (20) ayant une forme similaire au niveau de leurs sections transversales, chaque arête (20) étant globalement parallèle à l'arête (20) adjacente. Le motif B est superposé à une partie du motif A. Le motif B possède une surface globalement plane formant une marque plus petite mais similaire qui est soulignée par la marque du motif A. Dans un autre mode de réalisation, le motif A est superposé au motif B, tandis qu'un motif C est ajouté qui comprend des arêtes parallèles (40). Ces motifs peuvent former une bande décorative large et continue sur toute la circonférence, les marquages alphanumériques étant soulignés par une partie de la bande décorative large.
Patent EP-1032263-A1 (EP)
Inventor: DYER DAVID L
IPC: A61Q11/00
Filed: 1998-11-16
Abstract: Antimicrobial compositions and methods for preparing and using same are provided. The antimicrobial compositions are surfactant-based and contain certain benzalkonium chloride homologs. The compositions are useful in treating infections in animals and humans, and can be applied to areas including the skin, nails, and mouth.
Patent EP-1020094-A1 (EP)
Inventor: BREMER RAINER
IPC: H04Q7/38
Filed: 1998-10-01
Abstract: The invention relates to a method for authenticating subscribers to a digital mobile telephone network. The method aims to guarantee reliable authentication of subscribers wishing to make use of the service provision of the mobile radio network, but whose call number is not yet known to the mobile radio network. To this end, when the subscriber selects a special service offered in the mobile radio network by dialling a service access number, this service access number is recognized as such by the switching node of the mobile radio network responsible for call set-up. The invention is further characterized in that: recognition of the service access number causes automatic activation of a service logic which processes the call; the service logic automatically tests the presence of the call number (MSISDN) of the calling subscriber in the initial address message (IAM); on non-provision of the subscriber's call number (MSISDN) in the initial address message (IAM), the calling subscriber is automatically connected by the service logic to an appropriate network function for self-identification and authentication. Finally, after successful authentication by the service logic, the subscriber is automatically connected with the selected service.